A clinical trial found that tesofensine increased satiety, sense of fullness, and 24-h fat oxidation (fat burning) in overweight and obese individuals
MeAgain, can help you navigate the transition into GLP-1 medication therapy
Both forms of semaglutide are considered suitable for long-term use, but like any drug, each must be observed by a patients healthcare professional on an ongoing basis for signs of adverse effects over time
Recognising these symptoms is crucial for appropriate management, particularly when taking any new medication
Look at BMI along with waist size, activity level, and body composition when possible [22]
We prioritize sourcing premium-grade ingredients to deliver a product that exceeds expectations and sets a new standard in nutritional supplementation